Loss of either CD4+ or CD8+ T cells does not affect the magnitude of protective immunity to an intracellular pathogen, Francisella tularensis strain LVS
- PMID: 8943413
Loss of either CD4+ or CD8+ T cells does not affect the magnitude of protective immunity to an intracellular pathogen, Francisella tularensis strain LVS
Abstract
Normal mice readily survive a sublethal intradermal (i.d.) infection with Francisella tularensis live vaccine strain (LVS), a model intracellular bacterium, and are strongly protected against subsequent lethal challenge. However, athymic nu/nu mice, which lack mature alphabeta TCR+ T lymphocytes, succumb to i.d. infection within 30 days. Here we characterize the alphabeta T cell subpopulations necessary for both resolution of i.d. infection and generation of optimal protective immunity to LVS. BALB/cByJ mice treated with anti-CD4 or anti-CD8 Abs before i.d. infection survived and cleared bacteria, and anti-CD4- or anti-CD8-treated immune mice survived a very strong i.p. challenge of 10,000 LD50s. Among mutant mice with targeted gene disruptions (knockouts), CD4-, beta2-microglobulin-deficient (which are also CD8-), and gammadelta TCR- mice all resolved a large sublethal i.d. infection. All CD4- and beta2-microglobulin-deficient mice readily survived subsequent lethal i.p. challenge of 10,000 LD50s, even in the absence of specific IgG Abs, as did most (86%) gammadelta TCR- mice. In contrast, alphabeta TCR- mice or alphabeta + gammadelta TCR- mice died about 35 days after i.d. infection. Depletion of gammadelta+ T cells from alphabeta TCR- mice had no effect on mean time to death from i.d. LVS infection. Therefore alphabeta TCR+ cells are required for protection, but either CD4+ or CD8+ T cells are individually sufficient to resolve a large sublethal i.d. LVS infection and to protect against a maximal secondary lethal challenge. These results emphasize the remarkable plasticity of the alphabeta T cell response in protective immunity to intracellular bacteria.
Similar articles
-
A novel role for B cells in early protective immunity to an intracellular pathogen, Francisella tularensis strain LVS.J Immunol. 1997 Apr 1;158(7):3277-84. J Immunol. 1997. PMID: 9120284
-
CD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo.J Exp Med. 2005 Jul 18;202(2):309-19. doi: 10.1084/jem.20050569. J Exp Med. 2005. PMID: 16027239 Free PMC article.
-
Susceptibility to secondary Francisella tularensis live vaccine strain infection in B-cell-deficient mice is associated with neutrophilia but not with defects in specific T-cell-mediated immunity.Infect Immun. 2001 Jan;69(1):194-203. doi: 10.1128/IAI.69.1.194-203.2001. Infect Immun. 2001. PMID: 11119506 Free PMC article.
-
Nature of protective immunity to Francisella tularensis.Rev Infect Dis. 1989 May-Jun;11(3):440-51. Rev Infect Dis. 1989. PMID: 2665002 Review.
-
The role of T-cell subsets in Mycobacterium tuberculosis infection.Infect Agents Dis. 1996 Mar;5(2):73-81. Infect Agents Dis. 1996. PMID: 8721044 Review.
Cited by
-
Acetylcholine and an acetylcholinesterase inhibitor neostigmine can aggravate tularemia progress in BALB/c mice.Interdiscip Toxicol. 2012 Mar;5(1):21-4. doi: 10.2478/v10102-012-0004-7. Interdiscip Toxicol. 2012. PMID: 22783145 Free PMC article.
-
T cells from lungs and livers of Francisella tularensis-immune mice control the growth of intracellular bacteria.Infect Immun. 2009 May;77(5):2010-21. doi: 10.1128/IAI.01322-08. Epub 2009 Feb 23. Infect Immun. 2009. PMID: 19237526 Free PMC article.
-
A panel of correlates predicts vaccine-induced protection of rats against respiratory challenge with virulent Francisella tularensis.PLoS One. 2018 May 25;13(5):e0198140. doi: 10.1371/journal.pone.0198140. eCollection 2018. PLoS One. 2018. PMID: 29799870 Free PMC article.
-
Identification of T-cell epitopes in Francisella tularensis using an ordered protein array of serological targets.Immunology. 2011 Mar;132(3):348-60. doi: 10.1111/j.1365-2567.2010.03387.x. Epub 2011 Jan 7. Immunology. 2011. PMID: 21214540 Free PMC article.
-
Long lived protection against pneumonic tularemia is correlated with cellular immunity in peripheral, not pulmonary, organs.Vaccine. 2010 Sep 14;28(40):6562-72. doi: 10.1016/j.vaccine.2010.07.072. Epub 2010 Aug 3. Vaccine. 2010. PMID: 20688042 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials